MIF and breast cancer: Importantly, the present study highlights the novel contribution of identifying the WISP1/Src/MIF signaling axis as a key regulator of HA metabolism and EMT in ER+ breast cancer, providing new mechanistic insights into tumor plasticity and aggressiveness.